MOEHS集团。
世界的标杆

在快速增长且竞争激烈的市场中,MOEHS集团已发展成为全球主要供应商之一。

关键因素源于:

整合具有不同适应症的各种产品:从粘液溶解剂到β-受体阻滞剂。

不断扩展我们的 API 产品列表。

不断优化提供高性价比的服务。

不断听取客户的需求并付诸于行动,将其添加到我们的产品范围。

文件和法规的支持。

产品列表

产品名称CAS号码适应症Datos RegulatoriosFarmacopeasPlanta de producción
ACEBUTOLOL HCL34381-68-5Antianginal – Antihypertensive – AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021, JP 16M. CANTABRA & COPRIMA
AMANTADINE HCl665-66-7Antiviral -AntiparkinsonianCEP, EDMF USDMFPh. Eur. 10 USP-NF-2021, JP 16 M. CATALANA
AMLODIPINE BESILATE111470-99-6Antianginal – AntihypertensiveCEP, EDMF, USDMF, JDMF, KDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
ARTICAINE or CARTICAINE23964-57-0Local Anesthetic- AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021BENECHIM
BISOPROLOL FUMARATE104344-23-2AntihypertensiveCEP, EDMF, USDMF, JDMF, NDPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
CARBOCYSTEINE638-23-3MucolyticCEP, EDMF, JDMFPh. Eur. 10, JP 16M. CATALANA & M. BCN
CARBOCYSTEINE LYSINE SALT151756-26-2MucolyticEDMFin houseM. BCN
CARVEDILOL72956-09-3AntihypertensiveCEP, EDMF, USDMF, JDMF, KDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA & COPRIMA
CELIPROLOL HCI57470-78-7Antianginal- AntihypertensiveCEP, EDMF, JDMFPh. Eur. 10COPRIMA
CHOLINE FENOFIBRATE856676-23-8AntihyperlipidemicUSDMFIn houseCOPRIMA
DEXMEDETOMIDINE HCL145108-58-3SedativeDMFUSP-NF-2021NORCHIM & IBERICA
DULOXETINE HCL136434-34-9AntidepressantCEP, EDMF, USDMF, KDMFPh. Eur. 10, USP-NF-2021M. CANTABRA & M. BCN
FENOFIBRATE49562-28-9AntihyperlipidemicCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021COPRIMA
LANSOPRAZOLE103577-45-3AntiulcerativeCEP, EDMF, USDMF, JDMF, KDMFPh. Eur. 10, USP-NF-2021M. CATALANA
LIDOCAINE HCI6108-05-0Local Anesthetic-AntiarrhythmicCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021M. CATALANA & M. BCN
MEBEVERINE HCl2753-45-9AntispasmodicEDMF, NDPh. Eur., BP 2013BENECHIM
MEPIVACAINE HYDROCHLORIDE1722-62-9Local Anesthetic-AntiarrhythmicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
METOPROLOL TARTRATE 56392-17-7AntihypertensiveCEP, EDMF USDMF, JDMFPh. Eur. 10 USP-NF-2021, JP 16 M. CATALANA
N-ACETYLCYSTEINE616-91-1MucolyticCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA
NIFEDIPINE21829-25-4Antianginal-AntihypertensiveCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
NIFUROXAZIDE965-52-6AntidiarrhealEDMF, NDPh. Eur. 10COPRIMA
OLMESARTAN144689-63-4Cardiovascular angiotensin II antagonistEDMFPh. Eur. 10M. CATALANA
PANTOPRAZOLE SODIUM164579-32-2AntiulcerativeCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CANTABRA
PRILOCAINE BASE721-50-6Local AnestheticEDMF, USDMFPh. Eur. 9, USP-NF-2021BENECHIM
PYRANTEL EMBONATE22204-24-6AnthelminticEVMF, USVMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA & COPRIMA
QUETIAPINE FUMARATE111974-72-2AntipsychoticCEP, EDMF, USDMF, KDMFPh. Eur. 10, USP-NF-2021M. CANTABRA
RABEPRAZOLE SODIUM117976-90-6AntiulcerativeCEP, EDMF, USDMF, NDPh. Eur. 10M. CATALANA
ROPIVACAINE HCL132112-35-7Local AnestheticUSDMFPh. Eur. 10, USP-NF-2021BENECHIM
SOTALOL HCL959-24-0Antianginal-AntihypertensiveCEP, EDMF, USDMF, NDPh. Eur. 10, USP-NF-2021M. CATALANA
SUMATRIPTAN SUCCINATE103628-48-4AntimigraineEDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021M. CATALANA
TELMISARTAN144701-48-4CardiovascularEDMF, USDMF, CEPPh. Eur. 10, USP-NF-2021M. CATALANA
TRIAMTERENE396-01-0DiureticCEP, EDMF, USDMF, JDMFPh. Eur. 10, USP-NF-2021, JP 16M. CATALANA
TRIMEBUTINE MALEATE34140-59-5AntispasmodicCEP, EDMF, NDPh. Eur. 10, JP 16M. CATALANA & M. CANTABRA
VENLAFAXINE HCL99300-78-4AntispasmodicCEP, EDMF, USDMFPh. Eur. 10, USP-NF-2021M .CANTABRA

Productos en fase final de desarrollo

Nombre del productoCAS N°Categoría terapéuticaDisponibilidadDatos regulatoriosFarmacopea
EDOXABAN (**)1229194-11-9Oral anticoagulantValidation batchesDMF
EMPAGLIFLOZIN (**)864070-44-0AntidiabeticValidation batchesDMF
LEVOBUPIVACAINE HCL (**)27262-47-1Local Anesthetic-AntiarrhythmicValidation batchesTP
REMIMAZOLAM (**)308242-62-8SedativeLaboratory batchesTP
RIVAROXABAN (**)366789-02-8Antibleeding agentValidation batchesDMFPh. Eur.
SITAGLIPTIN HCL (**)862156-92-1AntidiabeticValidation batchesDMF
SITAGLIPTIN PHOSPHATE (**)654671-77-9AntidiabeticValidation batchesDMFUSP / Ph. Eur.
VILDAGLIPTIN (**)274901-16-5AntidiabeticValidation batchesDMF

(**) Moehs is working on this compound with experimental aims, exclusively directed to obtain market authorizations of our customers’ generic medicines. We don’t intend to make any activity against any valid patent protection, as well as we will not take charge of third party actions made with the provided compound and without our knowledge against this protection.

Productos en etapa inicial de desarrollo

Product NameCAS N°Therapeutic CategoryAdditional InformationDMF / TP
EDOXABAN (**)1229194-11-9Oral anticoagulant Validation batchesDMF
ELAGOLIX (**)832720-36-2Antialgic for endometriosis diseaseLaboratory batchesTP
EMPAGLIFLOZIN (**)864070-44-0AntidiabeticValidation batchesDMF
LASMIDITAN (**)439239-90-4AntimigraineLaboratory batchesTP
LEMBOREXANT (**)1369764-02-2Insomnia treatmentLaboratory batchesTP
LEVOBUPIVACAINE HCL27262-47-1
Local Anesthetic-Antiarrhythmic Validation batchesTP
OBETICHOLIC ACID (**)459789-99-2Liver and gastrointestinal disordersLaboratory batchesTP
PATIROMER CALCIUM SORBITEX (**)1260645-52-4HyperkalemiaLaboratory batchesTP
RELUGOLIX (**)737789-87-6Advanced prostate cancerLaboratory batchesTP
REMIMAZOLAM (**)308242-62-8
SedativeLaboratory batches TP
RIMEGEPANT (**)1289023-67-1AntimigraineLaboratory batchesTP
RIVAROXABAN (**)366789-02-8
Antibleeding agent Validation batchesDMF
SITAGLIPTIN PHOSPHATE (**)654671-77-9
AntidiabeticValidation batches DMF
VILDAGLIPTIN (**)274901-16-5
AntidiabeticValidation batches DMF

Nuevos Productos en evaluación

Product NameCAS N°Brand NameTherapeutic CategoryGalenic Form
MAVACAMTEN (**)1642288-47-8Cardiovascularcapsules
VERICIGUAT (**)1350653-20-1Antihypertensivetablets